---
current_phase: "0"
current_phase_name: "Database Build"
current_plan: "1 of 4"
total_phases: "10"
status: "in_progress"
progress: "[█░░░░░░░░░] 3%"
last_activity: "2026-05-05"
phase_count: 10
plan_count: 4
summary_count: 1
---

## Project Reference

See: SPEC.md (full project specification)

**Core value:** Trustworthy supplement/medication interaction analysis paired with a personalized smart schedule and reminders  
**Current focus:** Phase 0 — Database Build (pre-app, first deliverable)

---

## Current Position

Phase: 0 of 10 (Database Build)  
Plan: 1 of 4 complete in current phase  
Status: In progress  
Last activity: 2026-05-05 — Plan 00-01 (Stage 0 Pre-flight) complete; target list approved at D-04 gate  
Progress: [█░░░░░░░░░] 3%

---

## Accumulated Context

### Decisions

**Phase 0 (locked):**
- D-01: Working format is JSON (Stages 1–2); compile to SQLite after manual spot-check
- D-02: Single combined `stackwise.sqlite` (interactions + ingredients + metadata)
- D-03: metadata table with db_version (semantic) + date_built (ISO string)
- D-04: Target list researched by Claude, user-approved, saved as `research/target_list.json`
- D-05: Stage 1 collects target compounds first; broadens only if time allows
- D-06: Collect top brand-name aliases for all 20 target medications
- D-07: Hybrid execution — automated stages with human gate at each boundary
- D-08: Checkpoint-based multi-session (each stage reads prior stage output from disk)
- D-09: Minimum confidence for production records: medium and above
- D-10: Hard floor — every target compound must have ≥1 medium+ confidence record
- D-11/D-12: 7 baseline action templates in `research/action_templates.json`
- D-13: NIH ODS fact sheet titles as primary canonical name authority (lowercase_underscores)
- D-14: Generic name is canonical for medications; brand names are aliases
- D-15: Higher-confidence source's severity wins; ties favor higher severity; both sources cited
- D-16: `conflict_note` TEXT field added to interactions table when severity conflicts exist
- D-17: `timing_properties` as JSON blob TEXT column in ingredients table
- D-18: Four optional timing fields: requires_food, requires_empty_stomach, preferred_time_of_day, avoid_with_caffeine
- D-19: Regional scope is US retail; include traditional medicine if in approved sources
- D-20: Post-launch updates are on-demand, gap-report driven

### Execution Decisions (Plan 00-01)

- Added chromium, resveratrol, quercetin to reach exactly 50 supplements (plan enumerated 47 unique names; all three additions have known drug interactions and NIH ODS/MSK coverage)
- Target list approved by user at D-04 gate with no modifications — scope is now locked
- OPENFDA_API_KEY and NCBI_API_KEY confirmed registered in terminal session (not stored in files per T-0-01)
- pytest 9.0.2 already installed (not a new install)

### Pending Todos

- Set OPENFDA_API_KEY and NCBI_API_KEY environment variables before running Plan 00-02 (Stage 1 collection scripts)

### Blockers / Concerns

None.

---

## Deferred Items

None carried forward from previous milestone.

---

## Session Continuity

Last session: 2026-05-05  
Stopped at: Completed 00-01-PLAN.md (Stage 0 Pre-flight); target list approved at D-04 gate  
Resume file: None — next plan is 00-02-PLAN.md (Stage 1: Collection)
